2014-01299. Current Good Manufacturing Practice for Medicated Feeds

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Final rule, correcting amendment.

    SUMMARY:

    The Food and Drug Administration (FDA) is amending the regulations for good manufacturing practice of animal feeds containing a new animal drug to correctly cite the applicable section of the Federal Food, Drug, and Cosmetic Act (FD&C Act). This action is being taken to improve the accuracy of the regulations.

    DATES:

    This rule is effective January 23, 2014.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    George K. Haibel, Center for Veterinary Start Printed Page 3739Medicine (HFV-6), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9019, ghaibel@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    FDA has noticed the regulations for good manufacturing practice of animal feeds containing a new animal drug do not correctly cite the applicable section of the FD&C Act. At this time, FDA is making a correcting amendment in 21 CFR 225.1. This action is being taken to improve the accuracy of the regulations.

    Start List of Subjects

    List of Subjects in 21 CFR Part 225

    • Animal drugs
    • Animal feeds
    • Labeling
    • Packaging and containers
    • Reporting and recordkeeping requirements
    End List of Subjects

    Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 225 is amended as follows:

    Start Part

    PART 225—CURRENT GOOD MANUFACTURING PRACTICE FOR MEDICATED FEEDS

    End Part Start Amendment Part

    1. The authority citation for 21 CFR part 225 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 351, 352, 360b, 371, 374.

    End Authority
    [Amended]
    Start Amendment Part

    2. In § 225.1, in the last sentence in paragraph (b)(1), remove “section 402(a)(2)(D) of the act” and in its place add “section 402(a)(2)(C)(ii) of the act”.

    End Amendment Part Start Signature

    Dated: January 16, 2014.

    Leslie Kux,

    Assistant Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2014-01299 Filed 1-22-14; 8:45 am]

    BILLING CODE 4160-01-P

Document Information

Effective Date:
1/23/2014
Published:
01/23/2014
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule, correcting amendment.
Document Number:
2014-01299
Dates:
This rule is effective January 23, 2014.
Pages:
3738-3739 (2 pages)
Docket Numbers:
Docket No. FDA-2013-N-0002
Topics:
Animal drugs, Animal feeds, Labeling, Packaging and containers, Reporting and recordkeeping requirements
PDF File:
2014-01299.pdf
Supporting Documents:
» FREEDOM OF INFORMATION SUMMARY NADA 130-185 AMPROL 25% and FLAVOMYCIN Amprolium and Bambermycins
» FREEDOM OF INFORMATION SUMMARY Application Number 141-422 PACCAL VET-CA1 Paclitaxel for injection Powder for Injection Dog
» FREEDOM OF INFORMATION SUMMARY NADA141-420 TILDREN tiludronate disodium Powder for injection Horse
» FREEDOM OF INFORMATION SUMMARY NADA 141-361 PULMOTIL AC Tilmicosin Phosphate Aqueous Concentrate Swine
» FREEDOM OF INFORMATION SUMMARY NADA 141-246 AQUAFLOR Florfenicol
» Freedom of Information Summary NADA 141-288 EXCENEL RTU EZ Ceftiofur Hydrochloride
» Freedom of Information Summary NADA 095-735 RUMENSIN 90 Monensin
» Freedom of Information Summary NADA 141-406 NEXGARD Afoxolaner Chewable Tablet
» Freedom of Information Summary ANADA 200-548 ACTOGAIN 45 Ractopamine Hydrochloride Cattle fed in confinement for slaughter
» Freedom of Information Summary ANADA 200-542 ENGAIN 9 and ENGAIN 5 Ractopamine Hydrochloride Finishing Swine
CFR: (1)
21 CFR 225.1